SAGE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.69 USD | +0.81% |
|
+2.70% | -36.83% |
| 04-25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
| 04-25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
Chart calendar Sage Therapeutics, Inc.
bbf5e3.pR772HQz65VhoRuH6Zg9HGDVicw-8SKAta-her0Wx5s.kSmqihdrrPdS7F3Tn9pWTSTk4bZy3Brn5dbqO_5Js-POdoiXLga7_yTQfA~1ee6bb7b95af7cad3ff0a859b3f86d84
Upcoming events on Sage Therapeutics, Inc.
Past events on Sage Therapeutics, Inc.
| 25/04/2024 13:00 | Q1 2024 Earnings Call |
| 25/04/2024 11:30 | Q1 2024 Earnings Release |
| 17/04/2024 13:00 | PRECEDENT Phase 2 Study Results Call |
| 19/03/2024 17:30 | Stifel CNS Day |
| 05/03/2024 19:50 | TD Cowen Health Care Conference |
| 14/02/2024 13:00 | Q4 2023 Earnings Call |
| 14/02/2024 11:30 | Q4 2023 Earnings Release |
| 31/01/2024 14:00 | Extraordinary Shareholders Meeting |
| 09/01/2024 00:30 | JPMorgan Healthcare Conference |
| 30/11/2023 18:30 | Piper Sandler Healthcare Conference |
| 15/11/2023 14:10 | Stifel Healthcare Conference |
| 07/11/2023 13:00 | Q3 2023 Earnings Call |
| 07/11/2023 11:30 | Q3 2023 Earnings Release |
| 20/09/2023 20:00 | TD Cowen Novel Mechanisms in Neuropsychiatry Summit - Fireside Chat |
| 13/09/2023 17:15 | Morgan Stanley Global Healthcare Conference - Fireside Chat |
| 07/08/2023 13:00 | Q2 2023 Earnings Call |
| 07/08/2023 11:30 | Q2 2023 Earnings Release |
| 15/06/2023 13:30 | Annual General Meeting |
| 12/06/2023 19:20 | Goldman Sachs Global Healthcare Conference |
| 17/05/2023 16:30 | RBC Capital Markets Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6,87 8,72 -21.21% | 1 114 7,04 15716.57% | 6,31 6,48 -2.59% | 7,69 6,77 13.46% | 86,5 70,4 22.85% | 38,3 |
|
EBITDA Million USD | Released Forecast Spread | -706 -736 4.05% | 627 -479 230.69% | -457 -456 -0.07% | -546 -539 -1.31% | -578 -624 7.28% | -446 |
|
EBIT Million USD | Released Forecast Spread | -708 -728 2.79% | 624 -483 229.22% | -461 -463 0.43% | -547 -538 -1.66% | -580 -615 5.74% | -432 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -680 -701 2.9% | 606 -471 228.56% | -458 -457 -0.11% | -533 -528 -0.92% | -541 -582 6.89% | -401 |
|
Net income Million USD | Released Forecast Spread | -680 -700 2.85% | 606 -473 228.11% | -458 -459 0.25% | -533 -529 -0.75% | -541 -585 7.38% | -399 |
|
EPS USD | Released Forecast Spread | -13,4 -13,8 2.71% | 11,4 -9,07 226.04% | -7,80 -7,82 0.28% | -8,98 -8,89 -1.02% | -9,05 -9,66 6.33% | -6,63 |
| Announcement Date | 27/02/20 | 24/02/21 | 24/02/22 | 16/02/23 | 14/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,58 3,23 -50.98% | 1,50 1,77 -15.14% | 1,74 1,66 4.81% | 2,87 1,94 47.65% | 3,29 2,28 44.28% | 2,47 2,91 -15.1% | 2,72 3,17 -14.42% | 78,0 61,0 27.87% | 7,90 5,19 52.34% | 8,29 | 10,1 | 12,2 | 30,9 | 48,9 |
|
EBITDA Million USD | Released Forecast Spread | -119 -135 11.63% | -126 -134 6.59% | -140 -133 -5.76% | -154 -145 -6.05% | -158 -155 -2.21% | -175 -155 -12.37% | -183 -155 -17.91% | -35,5 -78,3 54.71% | ||||||
|
EBIT Million USD | Released Forecast Spread | -123 -122 -1.08% | -128 -128 0.02% | -141 -132 -7.23% | -154 -145 -6.16% | -155 -153 -1.7% | -170 -158 -7.98% | -178 -170 -4.71% | -42,1 -82,6 49.06% | -118 -107 -10.31% | -109 | -108 | -103 | -86,1 | -62,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -122 -121 -1.28% | -126 -127 0.54% | -137 -129 -6.09% | -147 -140 -5.1% | -147 -146 -0.86% | -160 -154 -3.88% | -202 -159 -26.41% | -32,7 -73,6 55.59% | -108 -101 -6.9% | -99,0 | -97,3 | -94,7 | -63,6 | -54,8 |
|
Net income Million USD | Released Forecast Spread | -122 -121 -1.01% | -126 -127 0.75% | -137 -130 -5.67% | -147 -142 -3.82% | -147 -149 1.42% | -160 -153 -4.76% | -202 -163 -23.42% | -32,7 -75,0 56.37% | -108 -101 -7.15% | -98,9 | -97,6 | -95,3 | -63,6 | -54,8 |
|
EPS USD | Released Forecast Spread | -2,07 -2,03 -2.08% | -2,13 -2,15 1.03% | -2,31 -2,20 -5.11% | -2,47 -2,39 -3.25% | -2,46 -2,52 2.34% | -2,68 -2,57 -4.3% | -3,37 -2,70 -25.01% | -0,55 -1,31 57.86% | -1,80 -1,66 -8.15% | -1,63 | -1,60 | -1,57 | -1,43 | -1,18 |
| Announcement Date | 03/05/22 | 02/08/22 | 08/11/22 | 16/02/23 | 02/05/23 | 07/08/23 | 07/11/23 | 14/02/24 | 25/04/24 | - | - | - | - | - |
More events
Past sector events for Sage Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SAGE Stock
- Calendar Sage Therapeutics, Inc.
